Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 26, 2026
Reporting period
Not applicable
Filed with the SEC
May 29, 2026
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001560409-26-000004
Filed / recorded
May 29, 2026, 12:25 AM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Medtronic plc
Issuer CIK
1613103
Ticker
MDT
Reporting person
Geoffrey Martha
Relationship
Director, Officer
Officer title
Chairman and CEO
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
May 26, 2026
Transaction code
M
Shares / units
94,963
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
343,099
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.
Includes 1,743 shares acquired through dividend reinvestment since the last report filed by the reporting person.